Ole Jesper Dahlberg • 1971 • Oslo • 12 roles • 5 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
I INITIA AS	Managing Director/CEO	-	2,209,641	100 % directly

Boards

Name	Role	Total operating income	Total equity	Shares
R RUBICON HEALTHCARE PARTNERS AS	Chairman	773,333	-211,194	35 % indirectly
R RUBICON CAPITAL HOLDING AS	Chairman	-	238,173	35 % indirectly
R RUBICON HEALTHCARE SPV I AS	Chairman	-	61,716,804	35 % indirectly
R RUBICON HEALTHCARE SPV II AS	Chairman	-	-	35 % indirectly
R RUBICON HEALTHCARE SPV III AS	Chairman	-	-	-
N NADENO NANOSCIENCE AS	Chairman	3,960,000	36,734,368	-
C CAEDO ONCOLOGY AS	Board Member	1,836,881	34,536,141	-
R RUBICON HEALTHCARE FUND I AS	Chairman	-	-	-
C CURIDA DIATEC AS	Chairman	20,135,856	37,207,995	-
C CURIDA HOLDING AS	Board Member	13,648,000	219,801,495	-
C CURIDA AS	Chairman	235,295,285	24,916,226	-

Last update: Aug 18, 2026

Related industries

3

Goods and trade
Purchase and sale
Industry and manufacturing
Process industry
Banking and insurance
Financial management

Direct relationships

5

SS
Sebastian Schmidt Intveen1988
RUBICON HEALTHCARE PARTNERS AS, RUBICON CAPITAL HOLDING AS, RUBICON HEALTHCARE SPV I AS, RUBICON HEALTHCARE SPV II AS, RUBICON HEALTHCARE SPV III AS, RUBICON HEALTHCARE FUND I AS
AP
Anders Per Erik Larsson1976
CURIDA HOLDING AS, CURIDA AS, CURIDA DIATEC AS
TG
Terje Gabrielsen1964
CURIDA AS, CURIDA DIATEC AS
EB
Espen Basmo Ellingsen1990
RUBICON HEALTHCARE PARTNERS AS, RUBICON HEALTHCARE SPV I AS
JH
Jon Hindar1956
CAEDO ONCOLOGY AS

Shares owned by Ole Jesper Dahlberg

Name	Share class	Total operating income	Total equity	Share
I INITIA AS	Ordinære aksjer	0	2,209,641	100 % directly
R RUBICON HEALTHCARE PARTNERS AS		773,333	-211,194	35 % indirectly
R RUBICON CAPITAL HOLDING AS		0	238,173	35 % indirectly
R RUBICON HEALTHCARE SPV I AS		0	61,716,804	35 % indirectly
R RUBICON HEALTHCARE SPV II AS		-	-	35 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Oct 30, 2026